These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 26075834)
1. Characterisation of liver-specific distribution of a novel 1-benzyl-4-aminoindole-based thyroid hormone receptor β agonist, SKL-13784: comparison with GC-1. Takahashi N; Izuchi T Xenobiotica; 2016; 46(2):108-16. PubMed ID: 26075834 [TBL] [Abstract][Full Text] [Related]
2. In vivo evaluation of 1-benzyl-4-aminoindole-based thyroid hormone receptor β agonists: importance of liver selectivity in drug discovery. Takahashi N; Asano Y; Maeda K; Watanabe N Biol Pharm Bull; 2014; 37(7):1103-8. PubMed ID: 24989002 [TBL] [Abstract][Full Text] [Related]
3. The thyroid hormone receptor-beta agonist GC-1 induces cell proliferation in rat liver and pancreas. Columbano A; Pibiri M; Deidda M; Cossu C; Scanlan TS; Chiellini G; Muntoni S; Ledda-Columbano GM Endocrinology; 2006 Jul; 147(7):3211-8. PubMed ID: 16574785 [TBL] [Abstract][Full Text] [Related]
4. Species differences in the biotransformation of an alpha 4 beta 2 nicotinic acetylcholine receptor partial agonist: the effects of distinct glucuronide metabolites on overall compound disposition. Shaffer CL; Gunduz M; Ryder TF; O'Connell TN Drug Metab Dispos; 2010 Feb; 38(2):292-301. PubMed ID: 19910512 [TBL] [Abstract][Full Text] [Related]
6. Glucuronidation and excretion of nonylphenol in perfused rat liver. Daidoji T; Inoue H; Kato S; Yokota H Drug Metab Dispos; 2003 Aug; 31(8):993-8. PubMed ID: 12867487 [TBL] [Abstract][Full Text] [Related]
7. In vivo activity of the thyroid hormone receptor beta- and α-selective agonists GC-24 and CO23 on rat liver, heart, and brain. Grijota-Martínez C; Samarut E; Scanlan TS; Morte B; Bernal J Endocrinology; 2011 Mar; 152(3):1136-42. PubMed ID: 21239431 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and pharmacological characterization of 1-benzyl-4-aminoindole-based thyroid hormone receptor β agonists. Takahashi N; Maeda K; Asano Y; Watanabe N Bioorg Med Chem; 2014 Jan; 22(1):488-98. PubMed ID: 24290064 [TBL] [Abstract][Full Text] [Related]
10. Sobetirome: a case history of bench-to-clinic drug discovery and development. Scanlan TS Heart Fail Rev; 2010 Mar; 15(2):177-82. PubMed ID: 19002578 [TBL] [Abstract][Full Text] [Related]
11. Thyroid receptor ligands. 1. Agonist ligands selective for the thyroid receptor beta1. Ye L; Li YL; Mellström K; Mellin C; Bladh LG; Koehler K; Garg N; Garcia Collazo AM; Litten C; Husman B; Persson K; Ljunggren J; Grover G; Sleph PG; George R; Malm J J Med Chem; 2003 Apr; 46(9):1580-8. PubMed ID: 12699376 [TBL] [Abstract][Full Text] [Related]
12. Biotransformation of a GABAA receptor partial agonist in sprague-dawley rats and cynomolgus monkeys: identification of two unique N-carbamoyl metabolites. Shaffer CL; Gunduz M; O'Connell TN; Obach RS; Yee S Drug Metab Dispos; 2005 Nov; 33(11):1688-99. PubMed ID: 16081672 [TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of a novel series of [1-(4-hydroxy-benzyl)-1H-indol-5-yloxy]-acetic acid compounds as potent, selective, thyroid hormone receptor β agonists. Burkholder TP; Cunningham BE; Clayton JR; Lander PA; Brown ML; Doti RA; Durst GL; Montrose-Rafizadeh C; King C; Osborne HE; Amos RM; Zink RW; Stramm LE; Burris TP; Cardona G; Konkol DL; Reidy C; Christe ME; Genin MJ Bioorg Med Chem Lett; 2015 Apr; 25(7):1377-80. PubMed ID: 25752984 [TBL] [Abstract][Full Text] [Related]
14. Thyroid hormone (T3) and TRbeta agonist GC-1 inhibit/reverse nonalcoholic fatty liver in rats. Perra A; Simbula G; Simbula M; Pibiri M; Kowalik MA; Sulas P; Cocco MT; Ledda-Columbano GM; Columbano A FASEB J; 2008 Aug; 22(8):2981-9. PubMed ID: 18434432 [TBL] [Abstract][Full Text] [Related]
15. The thyroid receptor β modulator GC-1 reduces atherosclerosis in ApoE deficient mice. Kannisto K; Rehnmark S; Slätis K; Webb P; Larsson L; Gåfvels M; Eggertsen G; Parini P Atherosclerosis; 2014 Dec; 237(2):544-54. PubMed ID: 25463087 [TBL] [Abstract][Full Text] [Related]
16. Discovery of novel indane derivatives as liver-selective thyroid hormone receptor β (TRβ) agonists for the treatment of dyslipidemia. Shiohara H; Nakamura T; Kikuchi N; Ozawa T; Nagano R; Matsuzawa A; Ohnota H; Miyamoto T; Ichikawa K; Hashizume K Bioorg Med Chem; 2012 Jun; 20(11):3622-34. PubMed ID: 22542282 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and metabolism of AMG 232, a novel orally bioavailable inhibitor of the MDM2-p53 interaction, in rats, dogs and monkeys: in vitro-in vivo correlation. Ye Q; Jiang M; Huang WT; Ling Y; Olson SH; Sun D; Xu G; Yan X; Wong BK; Jin L Xenobiotica; 2015; 45(8):681-92. PubMed ID: 25798742 [TBL] [Abstract][Full Text] [Related]
18. Differential effects of triiodothyronine and the thyroid hormone receptor beta-specific agonist GC-1 on thyroid hormone target genes in the b ain. Manzano J; Morte B; Scanlan TS; Bernal J Endocrinology; 2003 Dec; 144(12):5480-7. PubMed ID: 12959999 [TBL] [Abstract][Full Text] [Related]
19. Structural characterization of anti-HIV drug candidate PA-457 [3-O-(3',3'-dimethylsuccinyl)-betulinic acid] and its acyl glucuronides in rat bile and evaluation of in vitro stability in human and animal liver microsomes and plasma. Wen Z; Stern ST; Martin DE; Lee KH; Smith PC Drug Metab Dispos; 2006 Sep; 34(9):1436-42. PubMed ID: 16751262 [TBL] [Abstract][Full Text] [Related]
20. Disposition of a low dose of 14C-bisphenol A in male rats and its main biliary excretion as BPA glucuronide. Kurebayashi H; Betsui H; Ohno Y Toxicol Sci; 2003 May; 73(1):17-25. PubMed ID: 12700409 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]